PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25916750-6	2015	In patients with cHL receiving doxorubicin, bleomycin, vinblastine and dacarbazine, those expressing IGF-1R showed a trend towards better OS and event-free survival than IGF-1R-negative patients (P = 0.129 and P = 0.115 respectively), but statistical significance was not reached.	Bleomycin	44-53	insulin like growth factor 1 receptor	Homo sapiens	101-107	
32795835-6	2020	Blockage of IGF-1R decreases lung tissue damage and increases survival in bleomycin-induced as well as H1N1 influenza-related lung injury in animal models.	Bleomycin	74-83	insulin like growth factor 1 receptor	Homo sapiens	12-18